Medical Developments International Ltd
ASX:MVP
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Medical Developments International Ltd
ASX:MVP
|
AU |
|
Prada SpA
F:PRP
|
IT |
|
Petershill Partners PLC
LSE:PHLL
|
UK |
|
T
|
Teck Resources Ltd
TSX:TECK.A
|
CA |
|
Aehr Test Systems
NASDAQ:AEHR
|
US |
|
Bolsa Mexicana de Valores SAB de CV
OTC:BOMXF
|
MX |
|
S
|
SCB X PCL
SET:SCB
|
TH |
|
Harley-Davidson Inc
NYSE:HOG
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
British American Tobacco PLC
LSE:BATS
|
UK |
|
C
|
Case Group AB
STO:CASE
|
SE |
|
Vera Bradley Inc
NASDAQ:VRA
|
US |
|
4
|
4By4 Inc
KOSDAQ:389140
|
KR |
Wall St Price Targets
MVP Price Targets Summary
Medical Developments International Ltd
According to Wall Street analysts, the average 1-year price target for MVP is 0.867 AUD with a low forecast of 0.859 AUD and a high forecast of 0.893 AUD.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is MVP's stock price target?
Price Target
0.867
AUD
According to Wall Street analysts, the average 1-year price target for MVP is 0.867 AUD with a low forecast of 0.859 AUD and a high forecast of 0.893 AUD.
What is the Revenue forecast for Medical Developments International Ltd?
Projected CAGR
11%
Over the last 13 years, the compound annual growth rate for Revenue has been 10%. The projected CAGR for the next 4 years is 11%.
What is the Net Income forecast for Medical Developments International Ltd?
Projected CAGR
221%
Over the last 13 years, the compound annual growth rate for Net Income has been -23%. The projected CAGR for the next 4 years is 221%.
